Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP801039.RA_K9DpMyMNiFr89B6EbwdMkporeUpcY5-OlslyuwCyDo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801039.RA_K9DpMyMNiFr89B6EbwdMkporeUpcY5-OlslyuwCyDo130_assertion type Assertion NP801039.RA_K9DpMyMNiFr89B6EbwdMkporeUpcY5-OlslyuwCyDo130_head.
- NP801039.RA_K9DpMyMNiFr89B6EbwdMkporeUpcY5-OlslyuwCyDo130_assertion description "[The ability of PDE5 inhibitors to increase RV inotropy and to decrease RV afterload without significantly affecting systemic hemodynamics makes them ideal for the treatment of diseases affecting the RV, including pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801039.RA_K9DpMyMNiFr89B6EbwdMkporeUpcY5-OlslyuwCyDo130_provenance.
- NP801039.RA_K9DpMyMNiFr89B6EbwdMkporeUpcY5-OlslyuwCyDo130_assertion evidence source_evidence_literature NP801039.RA_K9DpMyMNiFr89B6EbwdMkporeUpcY5-OlslyuwCyDo130_provenance.
- NP801039.RA_K9DpMyMNiFr89B6EbwdMkporeUpcY5-OlslyuwCyDo130_assertion SIO_000772 17606845 NP801039.RA_K9DpMyMNiFr89B6EbwdMkporeUpcY5-OlslyuwCyDo130_provenance.
- NP801039.RA_K9DpMyMNiFr89B6EbwdMkporeUpcY5-OlslyuwCyDo130_assertion wasDerivedFrom befree-20150227 NP801039.RA_K9DpMyMNiFr89B6EbwdMkporeUpcY5-OlslyuwCyDo130_provenance.
- NP801039.RA_K9DpMyMNiFr89B6EbwdMkporeUpcY5-OlslyuwCyDo130_assertion wasGeneratedBy ECO_0000203 NP801039.RA_K9DpMyMNiFr89B6EbwdMkporeUpcY5-OlslyuwCyDo130_provenance.